Use of a novel eimeria gene and corresponding protein
AssigneeBayer HealthCare LLC
InventorsGisela Greif, Ralf Hosse, Jurgen Krucken, Frank Wunderlich
Life of this patent
Estimating the term…
Loading patent…
AssigneeBayer HealthCare LLC
InventorsGisela Greif, Ralf Hosse, Jurgen Krucken, Frank Wunderlich
Estimating the term…
The invention relates to a novel oocyst sporocyst protein (EtOs22) belonging to the parasite of the species Eimeria tenella and to the polynucleotide encoding this protein, to vectors which contain this polynucleotide, to cells which are transformed with these vectors, to antibodies which are directed against the protein, to vaccines which comprise the polynucleotide, the protein, or fragments thereof, the abovementioned vectors or antibodies directed against the protein, and to the use of polynucleotide or of polypeptide for finding active compounds for treating an infection with Eimeria and active compounds which are suitable for the therapy of an infection with Eimeria.
A polynucleotide comprising:
An active compound which modulates the activity of the EtOS22 protein during the excystation of sporozoites from sporocysts.
The use of an active compound which modulates the activity of the EtOS22 protein during the excystation of sporozoites from sporocysts for producing a drug for treating coccidiosis.
Dependencies are inferred from the claim text.